Lindestam Arlehamn

The aim of this work, in collaboration with Dr. Bjoern Peters, is to identify and characterize T cell epitopes from

Lindestam Arlehamn Lab
LJI Research Assistant Professor Cecilia Lindestam Arlehamn, Ph.D.
Cecilia Lindestam Arlehamn, Ph.D.
Research Assistant Professor
Center for Autoimmunity and Inflammation, Center for Sex-based Differences in the Immune System, Center for Vaccine Innovation

My laboratory is focused on understanding T cell immune responses to Mycobacterium tuberculosis and other infections, as well as self-antigens

Read More
Dec 13, 2021 Research News
Once upon a BCG vaccine

  LA JOLLA—A long, long time ago, the BCG vaccine was approved for use against tuberculosis (TB), and it’s still

Read More

T cell responses to Mycobacterium tuberculosis infection and vaccination: Following completion of a massive epitope discovery effort (also supported by


Investigation of human immune signatures of latent MTB infection, active disease and BCG vaccination. (NIH/NIAID, U19 AI118626) Proteome-wide characterization of

Sette Lab
Alessandro Sette, Dr.Biol.Sci.
Center for Autoimmunity and Inflammation - Director, Center for Cancer Immunotherapy, Center for Vaccine Innovation

Alessandro Sette, Dr.Biol.Sci., defines in chemical terms the specific structures (epitopes) that the immune system recognizes and uses this knowledge to measure and understand immune responses.

Read More
Sep 21, 2018 Immune Matters

The composition of an immune system varies not just from person to person, but over time—shifting as our health changes,

Read More
Apr 7, 2016 Immune Matters
Mapping T cells

An international team led by LJI investigator Alessandro Sette, Dr. Biol. Sci., characterizes the immune response to dengue virus and

Read More
Load More